Clinical trial
A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of…
NCT00203905 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00203905 |
|---|---|
| Title | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck |
| Official title | A Randomized Phase II Study of Concomitant Chemoradiotherapy With 5-Fluorouracil/Hydroxyurea Compared to FHX Plus Bevacizumab for Intermediate Stage and Selected Stage IV Cancers of the Head and Neck |
| Lead sponsor | University of Chicago, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | 5-Fluorouracil, Hydroxyurea-[FHX], Bevacizumab |
| Enrollment | 23 |
| Start date | Jan 1, 2004 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: